SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-016958
Filing Date
2019-11-13
Accepted
2019-11-13 06:16:15
Documents
62
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 732394
2 logo_001.jpg GRAPHIC 19669
3 ex31-1.htm EX-31.1 11240
4 ex31-2.htm EX-31.2 11338
5 ex32-1.htm EX-32.1 8103
  Complete submission text file 0001493152-19-016958.txt   3751683

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE mtnb-20190930.xml EX-101.INS 535585
7 XBRL SCHEMA FILE mtnb-20190930.xsd EX-101.SCH 50990
8 XBRL CALCULATION FILE mtnb-20190930_cal.xml EX-101.CAL 58271
9 XBRL DEFINITION FILE mtnb-20190930_def.xml EX-101.DEF 193807
10 XBRL LABEL FILE mtnb-20190930_lab.xml EX-101.LAB 356681
11 XBRL PRESENTATION FILE mtnb-20190930_pre.xml EX-101.PRE 264836
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-443-1860
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38022 | Film No.: 191211629
SIC: 2834 Pharmaceutical Preparations